Zappy Health Pricing Explained: First-Month Rate vs Refill Costs

Last reviewed: September 18, 2026 Last updated: September 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Zappy Health's official pages display conflicting pricing structures as of September 4, 2026. One page shows an advertised first-month rate of $159/month for compounded semaglutide and $279/month for compounded tirzepatide with no stated duration limits. Another official page shows $199/month for semaglutide (first three months) then $295/month ongoing, and $299/month for tirzepatide (first three months) then $359/month ongoing. We did not complete checkout verification, so binding renewal pricing remains unconfirmed. If the introductory-to-refill structure is accurate, year-one semaglutide costs $3,252 ($271/month effective rate) and year-two-plus costs $3,540 annually ($295/month). For tirzepatide, year one totals $4,128 ($344/month effective) and year two-plus runs $4,308 annually ($359/month). PlexusDx charges a flat $189/month month-to-month for compounded semaglutide injection and $289/month month-to-month for compounded tirzepatide injection with month-to-month billing—no introductory period, no price increase at refill—or $149 and $249 per month respectively on prepaid six-month plans. If Zappy's lower advertised figures reflect true ongoing rates rather than limited-time offers, the economic comparison shifts substantially. Readers should confirm pricing and renewal terms during intake before committing to long-term treatment.

Zappy Health pricing: documented structures

As of our September 4, 2026 capture, two distinct pricing models appear on official Zappy Health pages. The conflict is documented in primary sources and creates uncertainty about binding long-term costs.

The landing page figures (advertised first-month $159 semaglutide, $279 tirzepatide) do not specify whether they represent ongoing rates or limited introductory pricing. The alternative page explicitly describes a three-month introductory period followed by higher refill pricing. Our research team classified this evidence as "Primary-conflict" with the note "Binding renewal price requires intake." We did not complete a checkout flow to verify which structure applies at purchase.

12-month cost analysis under both scenarios

Because Zappy Health's official pages conflict, we calculate annual costs under both documented pricing structures. All 12-month totals below are our calculations based on the monthly rates documented on September 4, 2026.

Scenario A: If landing-page pricing is the ongoing rate

Under this scenario, Zappy Health's advertised semaglutide rate saves $360 per year compared to PlexusDx month-to-month, but costs $120 more annually than PlexusDx's prepaid six-month plan. For tirzepatide, Zappy saves $120 yearly versus PlexusDx month-to-month and costs $360 more than the PlexusDx six-month plan.

Scenario B: If introductory-to-refill pricing is accurate

This structure features an advertised first-month or first-three-month introductory rate, followed by a higher refill price. We calculate the blended first-year cost and the ongoing year-two-plus cost separately.

Under this scenario, Zappy Health semaglutide costs $984 more than PlexusDx month-to-month in year one, and $1,272 more per year from year two onward. Tirzepatide runs $660 more in year one and $840 more annually thereafter compared to PlexusDx month-to-month. The PlexusDx six-month prepaid plan (semaglutide $1,788/year, tirzepatide $2,988/year) widens the gap further.

What the pricing conflict means for long-term treatment

The documented conflict between Zappy Health's official pages creates practical uncertainty for patients planning multi-month or multi-year treatment. If the landing page's advertised first-month semaglutide and tirzepatide figures represent true ongoing rates, Zappy offers competitive pricing versus many month-to-month alternatives. If the introductory-to-refill structure ($199→$295, $299→$359) applies, first-year costs are higher than the landing page suggests, and year-two-plus costs exceed PlexusDx month-to-month pricing by $1,272 annually for semaglutide and $840 for tirzepatide.

We did not complete a checkout flow or intake process, so we cannot confirm which pricing model applies at the point of purchase or which figure appears on the credit-card charge. The research note "Binding renewal price requires intake" reflects this limitation. Patients evaluating Zappy Health for long-term use should confirm the binding monthly rate, the duration of any introductory pricing, and the refill price before committing.

PlexusDx pricing structure

PlexusDx charges $189/month month-to-month for compounded semaglutide injection and $289/month month-to-month for compounded tirzepatide injection on month-to-month plans. The rate holds at every dose and every refill—no introductory period, no price increase after the first shipment. Patients who prefer predictable costs and are comfortable committing upfront may choose three-month plans (semaglutide $169/month, tirzepatide $269/month, prepaid per-month equivalent) or six-month plans (semaglutide $149/month, tirzepatide $249/month, prepaid per-month equivalent). No separate membership fee applies; medication price includes the provider visit, prescription, compounding, and shipping. PlexusDx works with licensed 503A compounding pharmacies.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Medication and regulatory status

Both Zappy Health and PlexusDx offer compounded semaglutide and compounded tirzepatide injections. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Zappy Health also maintains a pathway to branded Zepbound (tirzepatide) for patients who prefer an FDA-approved medication and meet eligibility criteria (documented September 4, 2026). Branded medications typically carry higher list prices and may require prior authorization or meet-deductible spending under insurance.

Choose Zappy Health if…

• You confirm during intake that the advertised semaglutide or tirzepatide rate applies as an ongoing price (not a limited introductory offer), and that pricing beats your comparison set over 12 months.
• You prefer a provider that offers both compounded and branded medication pathways, giving you a potential switch option if compounding availability changes.
• The Zappy Health intake and customer-support experience aligns with your preferences after you review their process details.

Choose PlexusDx if…

• You want published pricing that does not require intake confirmation—the same $189 semaglutide / $289 tirzepatide month-to-month rate appears on the product page, in email confirmation, and on every refill invoice.
• You value long-term cost predictability and plan to stay on treatment for six months or longer, making the prepaid plans ($149 semaglutide / $249 tirzepatide per month on six-month commitment) worth considering.
• You prefer working with a provider that holds a 4.3-star Trustpilot rating with 83% of reviews at four stars or higher (captured September 9, 2026).
• You want a no-membership-fee structure where one monthly payment covers your visit, prescription, medication, and shipping with no separate line items.

Methodology and freshness

We captured Zappy Health pricing from official company pages on September 4, 2026. The documented conflict—advertised rates on one page, introductory-to-refill structure on another—appears in primary sources indexed during the same session. We did not complete checkout or intake, so binding renewal pricing remains unverified. We calculated all 12-month cost totals by multiplying the documented monthly rates; these are our calculations, not figures published by Zappy Health. PlexusDx pricing is current as of September 18, 2026. PlexusDx review data was captured from Trustpilot on September 9, 2026. Readers should confirm all pricing, refill rates, and commitment terms directly with each provider before purchasing, as rates and promotional structures may change.

Frequently Asked Questions

Does Zappy Health charge an introductory rate that increases at refill?

One official Zappy Health page shows $199/month for semaglutide (first three months) rising to $295/month ongoing, and $299/month for tirzepatide (first three months) rising to $359/month ongoing, documented September 4, 2026. Another page shows advertised rates with no stated duration limit. We did not complete checkout, so binding renewal pricing is unconfirmed. Confirm the refill rate during intake before committing.

How much does Zappy Health semaglutide cost over 12 months?

If the landing-page advertised rate is ongoing, 12 months totals $1,908 (our calculation). If the introductory-to-refill structure ($199 for three months, then $295 ongoing) applies, year one costs $3,252 and subsequent years cost $3,540 annually (our calculations based on documented rates captured September 4, 2026). Confirm pricing at intake.

Does PlexusDx raise the price after the first month?

No. PlexusDx charges $189/month month-to-month for semaglutide injection and $289/month month-to-month for tirzepatide injection on month-to-month plans, and that rate holds at every dose and every refill. Prepaid three-month and six-month plans offer lower per-month rates ($149 semaglutide, $249 tirzepatide on six-month plans, prepaid per-month equivalent) with no price increase during the commitment period.

Are compounded GLP-1 medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Zappy Health and PlexusDx offer compounded semaglutide and tirzepatide; Zappy also offers a branded Zepbound pathway for patients who prefer an FDA-approved medication.

Which provider costs less over two years of semaglutide treatment?

If Zappy's advertised rate is ongoing, two years totals $3,816 versus PlexusDx month-to-month at $4,536 (our calculations). If Zappy's introductory-to-refill structure applies, two years totals $6,792 versus PlexusDx month-to-month at $4,536, and PlexusDx six-month prepaid plans run $3,576 over two years (our calculations based on documented rates). Confirm Zappy's binding renewal rate at intake.

Sources

• Zappy Health official pages (zappyhealth.com/compounded-tirzepatide/ and related pages; accessed September 4, 2026)
• PlexusDx product pages and pricing (plexusdx.com; accessed September 18, 2026)
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com; accessed September 9, 2026)
• Zappy Health Trustpilot profile (trustpilot.com/review/zappyhealth.com; accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.